BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23982724)

  • 21. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma.
    Chiang FY; Wu CW; Hsiao PJ; Kuo WR; Lee KW; Lin JC; Liao YC; Juo SH
    Clin Cancer Res; 2008 Sep; 14(18):5919-24. PubMed ID: 18779313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
    Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
    Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association.
    Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Chen C
    Gynecol Oncol; 2006 Dec; 103(3):891-6. PubMed ID: 16806437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients.
    Strom SS; Estey E; Outschoorn UM; Garcia-Manero G
    Leuk Lymphoma; 2010 Apr; 51(4):598-605. PubMed ID: 20141440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
    Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis.
    Ho T; Li G; Lu J; Zhao C; Wei Q; Sturgis EM
    Thyroid; 2009 Feb; 19(2):129-35. PubMed ID: 19191745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
    Qiu L; Wang Z; Shi X; Wang Z
    Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
    Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
    Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population.
    Ruiz-Cosano J; Torres-Moreno D; Conesa-Zamora P
    J BUON; 2013; 18(2):486-90. PubMed ID: 23818366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
    Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
    Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
    Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between nucleotide excision repair gene polymorphism and colorectal cancer risk.
    Zhang Y; Wu S; Zhou X; Huang F; Chen R; Wang Y; Wu J
    J Clin Lab Anal; 2019 Oct; 33(8):e22956. PubMed ID: 31568607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies.
    Ding DP; He XF; Zhang Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):203-9. PubMed ID: 21424776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
    Guillem VM; Cervantes F; Martínez J; Alvarez-Larrán A; Collado M; Camós M; Sureda A; Maffioli M; Marugán I; Hernández-Boluda JC
    Am J Hematol; 2010 Jul; 85(7):482-6. PubMed ID: 20575039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.